By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



9901 IH 10 West
Suite 800
San Antonio  Texas  78230  U.S.A.
Phone: 210-477-8537 Fax: n/a



Company News
GenSpera Release: Mipsagargin Demonstrates Clinical Benefit In Subset Of Glioblastoma Patients 11/20/2015 11:04:34 AM
GenSpera Provides Update On Clinical Development Programs 11/13/2015 12:05:24 PM
World-Renowned Neuro-Oncologist Santosh Kesari, MD, PhD Joins GenSpera’s Scientific Advisory Board 10/29/2015 11:26:00 AM
GenSpera To Present At The BIO Investor Forum 10/14/2015 4:15:01 PM
GenSpera Announces Encouraging Interim Phase II Data For Glioblastoma, Showcases Positive Future For Mipsagargin Across Multiple Types Of Solid Tumors 9/9/2015 11:55:58 AM
GenSpera To Present At Rodman & Renshaw 17th Annual Global Investment Conference 8/25/2015 9:55:30 AM
GenSpera Provides 2nd Quarter Corporate Update 8/12/2015 10:07:27 AM
GenSpera Phase II Abstract Accepted For Presentation At The Society Of Neuro-Oncology 20th Annual Scientific Meeting 7/28/2015 11:37:32 AM
U.S. Court Of Appeals Enters Judgment In Favor Of GenSpera 7/20/2015 10:44:05 AM
Patent Application For GenSpera Partner Phyton Biotech, Inc. Is Published By World Intellectual Property Organization (WIPO) 7/13/2015 10:08:28 AM